Full Library

Return to list of results

Interleukin-1 Targeted Agents

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Book Section
Authors/contributors
Title
Interleukin-1 Targeted Agents
Abstract
Introduction and Aims: Inhibition of the IL-1 pathway has been the target of treatments for several inflammatory conditions. This clinical review aims to summarize the risk of infectious complications associated with the use of interleukin-1 (IL-1) targeted therapy.
Book Title
Infectious Complications in Biologic and Targeted Therapies
Date
2022
Publisher
Springer International Publishing
Place
Cham
Pages
173-185
ISBN
978-3-031-11363-5
URL
https://doi.org/10.1007/978-3-031-11363-5_9
Accessed
11/27/22, 5:23 PM
Language
en
Library Catalog
Springer Link
Extra
DOI: 10.1007/978-3-031-11363-5_9
Citation
Alam, M., Mah, A., & Belga, S. (2022). Interleukin-1 Targeted Agents. In C. Cervera & J. M. Aguado (Eds.), Infectious Complications in Biologic and Targeted Therapies (pp. 173–185). Springer International Publishing. https://doi.org/10.1007/978-3-031-11363-5_9
HEME-ONC AND CELLULAR THERAPIES
Link to this record
https://www.transplantid.net/LFQY9RTQ